We are live on ! Find out more
LFCR icon

Lifecore Biomedical
LFCR

79 hedge funds and large institutions have $114M invested in Lifecore Biomedical in 2024 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 23 increasing their positions, 20 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

58% more call options, than puts

Call options by funds: $778K | Put options by funds: $492K

15% more repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 20

1% more funds holding

Funds holding: 78 → 79 (+1)

7% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 15

2% less ownership

Funds ownership: 72.57% → 70.57% (-2%)

16% less capital invested

Capital invested by funds: $136M → $114M (-$21.8M)

20% less funds holding in top 10

Funds holding in top 10: 5 → 4 (-1)

Holders
79
Holders Change
+1
Holders Change %
+1.28%
% of All Funds
1.14%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.06%
New
16
Increased
23
Reduced
20
Closed
15
Calls
$778K
Puts
$492K
Net Calls
+$286K
Net Calls Change
-$159K

Top Buyers

Rank Fund Capital Flow
1
CSC
Cove Street Capital
California
+$2.67M
2
Jane Street
Jane Street
New York
+$1.14M
3
2C
272 Capital
Texas
+$1.04M
4
3C
325 Capital
New York
+$956K
5
QOP
Quinn Opportunity Partners
Virginia
+$678K

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$5.62M
2
GRIM
Greenhaven Road Investment Management
Connecticut
-$1.59M
3
Vanguard Group
Vanguard Group
Pennsylvania
-$1.19M
4
BlackRock
BlackRock
New York
-$862K
5
DC
Defender Capital
North Carolina
-$535K
Name Holding Trade Value Shares
Change 		Change in
Stake
QOP
26
Quinn Opportunity Partners
Virginia
$503K +$678K +94,813 New
Goldman Sachs
27
Goldman Sachs
New York
$466K +$387K +54,106 +161%
BCM
28
Bridgeway Capital Management
Texas
$408K +$550K +76,900 New
GI
29
GAMCO Investors
Connecticut
$405K -$2.15K -300 -0.4%
RA
30
Royce & Associates
New York
$401K – – –
BFM
31
Boothbay Fund Management
New York
$372K +$419K +58,581 +508%
Northern Trust
32
Northern Trust
Illinois
$327K -$129 -18 -0%
American Century Companies
33
American Century Companies
Missouri
$316K +$27K +3,775 +7%
DT
34
Diversified Trust
Tennessee
$245K – – –
OAM
35
Oppenheimer Asset Management
New York
$228K +$137K +19,094 +80%
Balyasny Asset Management
36
Balyasny Asset Management
Illinois
$198K -$263K -36,813 -50%
BHCM
37
Brevan Howard Capital Management
Jersey
$174K +$234K +32,785 New
UBS Group
38
UBS Group
Switzerland
$132K -$365K -50,975 -67%
YIH
39
Y-Intercept (HK)
Hong Kong
$130K +$77.7K +10,867 +79%
Assenagon Asset Management
40
Assenagon Asset Management
Luxembourg
$127K – – –
KA
41
Keene & Associates
Texas
$119K +$3.4K +475 +2%
MTIM
42
Marathon Trading Investment Management
Pennsylvania
$106K +$142K +19,900 New
Boston Partners
43
Boston Partners
Massachusetts
$104K +$141K +19,674 New
GF
44
Gabelli Funds
New York
$101K +$5.01K +700 +4%
JFG
45
Jefferies Financial Group
New York
$99.3K +$7.15K +1,000 +6%
Bank of America
46
Bank of America
North Carolina
$90.8K -$124K -17,313 -50%
PWPS
47
Pinnacle Wealth Planning Services
Ohio
$82.2K -$16.1K -2,254 -13%
State Board of Administration of Florida Retirement System
48
State Board of Administration of Florida Retirement System
Florida
$81.3K +$154K +21,544 New
RC
49
RBF Capital
California
$73.4K +$98.8K +13,815 New
XT
50
XTX Topco
Cayman Islands
$67K +$90.2K +12,610 New
1
2
3 4

LFCR Hedge Fund Activity: Q1 2024 in Review

79 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Lifecore Biomedical (LFCR) for Q1 2024, worth a combined $114M — down 16% from $136M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new LFCR positions and 15 closed out — a net gain of 1 holder — while 23 added to existing stakes and 20 trimmed.

The largest buyer was Cove Street Capital, adding an estimated $2.67M. The largest seller was Morgan Stanley, cutting an estimated $5.62M.

  • 79 institutional investors held Lifecore Biomedical (LFCR) as of Q1 2024, up from 78 in Q4 2023.
  • Funds reported $114M of Lifecore Biomedical stock for Q1 2024, down 16% quarter-over-quarter.
  • 16 funds opened new Lifecore Biomedical positions in Q1 2024 and 15 closed out, a net change of +1 holder.
  • The largest Lifecore Biomedical buyer in Q1 2024 was Cove Street Capital, an estimated $2.67M added.
  • The largest Lifecore Biomedical seller in Q1 2024 was Morgan Stanley, an estimated $5.62M sold.

Based on aggregated 13F filings for Q1 2024.